3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
9
Melanoma
4
Ganglioneuroblastoma
4
Triple Negative Breast Neoplasms
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
2
Adenoma, Islet Cell
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Transplant-Related Hematologic Malignancy
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Alveolar Soft Part
1
Recurrence
1
Prostatic Neoplasms
1
Pathologic Complete Response
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma
1
Locally Advanced Pancreatic Adenocarcinoma
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Hodgkin Disease
1
Gliosarcoma
1
Glioblastoma
1
Endometrial Neoplasms
1
Carcinosarcoma
1
Carcinoma, Transitional Cell
1
Interventions
mogamulizumab
7
Specimen Handling
5
Immunoglobulin G
5
Disulfides
5
Cyclophosphamide
5
Biopsy
5
pembrolizumab
4
fludarabine
4
Magnetic Resonance Spectroscopy
4
Brentuximab Vedotin
4
hypericin
3
fludarabine phosphate
3
cemiplimab
3
Radiotherapy
3
Nivolumab
3
sodium-iodide symporter
2
X-Rays
2
Whole-Body Irradiation
2
Tacrolimus
2
Phototherapy
2
Photons
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Busulfan
2
talimogene laherparepvec
1
ruxolitinib
1
romidepsin
1
magrolimab
1
duvelisib
1
durvalumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mycosis Fungoides
×
sargramostim
×
1 year
×
Clear all
No trials found.